Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Adrenal Cortex Neoplasms × tariquidar × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Uterine Cervical Neoplasms 1 Ovarian Neoplasms 1 Neoplasms 1 Lung Neoplasms 1 Kidney Neoplasms 1 Endocrine Gland Neoplasms 1 Adrenal Cortex Neoplasms 1

Interventions

relacorilant 2 cabozantinib 2 tariquidar 1 pembrolizumab 1 Specimen Handling 1 Pharmacogenomic Variants 1 Pharmacogenomic Testing 1 Osilodrostat 1 Nivolumab 1 Magnetic Resonance Spectroscopy 1 Gefitinib 1 Floxuridine 1 Dexamethasone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00071058 2012-09-18

Surgery Plus Chemotherapy (Doxorubicin, Vincristine and Etoposide), Mitotane, and Tariquidar to Treat Adrenocortical Cancer

National Institutes of Health Clinical Center (CC)

Phase 2 Completed

50 enrolled 10 charts

Adrenal Cortex Neoplasms, Endocrine Gland Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡